Advanced in Paris-Trousseau Thrombocytopenia

Sophie Bayart

Rennes, FR 
Advanced in Paris-Trousseau Thrombocytopenia
Rennes, FR 
OverviewLocationsClinical Research

Overview

Sophie Bayart practices in Rennes, France. Ms. Bayart is rated as an Advanced expert by MediFind in the treatment of Paris-Trousseau Thrombocytopenia. Her top areas of expertise are Evans Syndrome, Blood Clots, Autoimmune Hemolytic Anemia, Hemophilia A, and Splenectomy.

Her clinical research consists of co-authoring 36 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Paris-Trousseau Thrombocytopenia.

Gender
Female

Locations

Rennes, France
Other Locations
Nice, France
Bordeaux, France
Bretagne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Biological
Study Drugs: PEG-Factor VIII, Eloctate ITI
Study Phase: Phase 3
Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Enrollment Status: Completed
Publish Date: February 14, 2023
Intervention Type: Other
View 1 Less Clinical Trial

36 Total Publications

Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched study.
Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched study.
Journal: Blood advances
Published: June 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bayart's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile